Application 212287
- Type
- ANDA
- Sponsor
- ASTRAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | No | No |
| 002 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | No | No |
| 003 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A212287-001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | ||
| A212287-002 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | ||
| A212287-003 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2024-10-29 15:01 UTC | 2024-10 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2019-07-29 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | A212287-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A212287-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | A212287-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | AP | 2019-07-29 | 8869cabd3fbd… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212287-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212287-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A212287-003 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A212287-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A212287-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A212287-003 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A212287-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A212287-002 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A212287-003 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A212287-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A212287-002 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A212287-003 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A212287-001 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A212287-002 | AP | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A212287-003 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A212287-001 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A212287-002 | AP | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A212287-003 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A212287-001 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A212287-002 | AP | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A212287-003 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A212287-001 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A212287-002 | AP | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A212287-003 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A212287-001 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A212287-002 | AP | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A212287-003 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A212287-001 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A212287-002 | AP | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A212287-003 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A212287-001 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A212287-002 | AP | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A212287-003 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A212287-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A212287-002 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A212287-003 | AP | 1 | b00525d2431f… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212287-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212287-002 | AP | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A212287-003 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A212287-001 | AP | 1 | 1c564ffb4f44… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Armas Pharmaceuticals Inc. | bbd1e6ae-e19a-4572-a0ec-e78c8aa31d2a | 2026-10-22 | Warnings, Adverse reactions | piperacillin and tazobactam |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Armas Pharmaceuticals Inc. | 24d9b4f1-109c-4db4-8a99-03afff045b47 | 2026-10-22 | Warnings, Adverse reactions | piperacillin and tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c8e3cc43-238d-4a23-95dc-157c85f83184 | 2026-10-05 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | WG Critical Care, LLC | 17a400ae-cbaa-4d07-95f4-c6917dfc0585 | 2026-09-22 | Boxed warning, Warnings, Adverse reactions | Piperacillin and Tazobactam |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN AND TAZOBACTAM | MILLA PHARMACEUTICALS INC. | 6e5784d6-a850-463e-ac19-8ce87331ef68 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | PIPERACILLIN AND TAZOBACTAM |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | a798faf5-cd97-4e35-a700-94c372978c46 | 2026-09-02 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | WG Critical Care, LLC | 2cd82553-79dc-45f0-9755-2c08df524ed5 | 2026-08-31 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Civica, Inc. | 7aebc0e6-89db-4ef0-b5ab-d6b3199bcfc4 | 2025-09-08 | Warnings, Adverse reactions | piperacillin and tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | 39e19789-de4b-4fd1-ab1c-92f59496f496 | 2025-08-19 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | a5d8625e-e630-4076-bc55-46ebe861c6a5 | 2025-08-08 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | ONESOURCE SPECIALTY PHARMA LIMITED | 28258745-12e4-4f0f-b318-4a1a1bebc928 | 2025-07-21 | Warnings, Adverse reactions | piperacillin and tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | BluePoint Laboratories | 1aba753c-d0c2-4b35-917a-9143dd4be468 | 2025-06-20 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Apotex Corp. | 2c8f06a2-49b2-4169-94ef-182d13d248bf | 2025-05-21 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c5cddf50-e486-4ffb-9bc6-ed67ad6bc154 | 2025-04-14 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | 6a894b94-171f-4217-81a2-0e84796b0b41 | 2025-04-11 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | 68d5384d-1691-4afc-8a1a-488f8e2ef2c5 | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | Piperacillin and Tazobactam |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | bc26ffd8-1a6e-4e16-91c1-ec67c928b3bf | 2025-02-26 | Warnings, Adverse reactions | PIPERACILLIN AND TAZOBACTAM |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Sandoz Inc | 9b682c66-61c6-4ade-baf4-9d68911a16b8 | 2024-10-30 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Hospira, Inc | 4d3f4b69-b0b9-494f-9cda-4537fa420d47 | 2024-10-25 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | 420196a5-f62d-473f-84d8-d7fc3f31c3d3 | 2024-10-17 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 66794-216 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-216 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-216 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-216 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-216 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-216 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-216 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-217 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-217 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-217 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-217 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-217 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-217 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-217 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-218 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-218 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-218 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-218 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-218 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-218 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 66794-218 | Piperacillin and Tazobactam | Piperacillin and Tazobactam | Piramal Critical Care Inc | ANDA | Current |
| 70594-078 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-078 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-078 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-079 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-079 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-079 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-080 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-080 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 70594-080 | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | PIPERACILLIN SODIUM and TAZOBACTAM SODIUM | Xellia Pharmaceuticals USA LLC | ANDA | Current |
| 71288-002 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-002 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-002 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-003 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-003 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-003 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-004 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-004 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-004 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 72572-575 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Civica, Inc. | ANDA | Current |
| 72572-575 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Civica, Inc. | ANDA | Current |
| 72572-576 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Civica, Inc. | ANDA | Current |
| 72572-576 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Civica, Inc. | ANDA | Current |
| 72572-577 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Civica, Inc. | ANDA | Current |
| 72572-577 | Piperacillin and Tazobactam | Piperacillin Sodium and Tazobactam Sodium | Civica, Inc. | ANDA | Current |